Day Two: Tuesday, June 3, 2025Tuesday, June 3, 2025 - ET (Eastern Time, GMT-05:00)

• Examine the current US regulatory landscape and gain deep insights into recent OIG and DOJ guidance, enforcement trends, and compliance program expectations

  • Learn how to evaluate and implement effective compliance monitoring and voluntary disclosure practices that meet DOJ and OIG expectations

  • Understand how US compliance trends influence Canadian regulations while identifying strategic opportunities for cross-border collaboration and maintaining seamless compliance across both jurisdictions

• Examine how the expansion of private healthcare is driving shifts in the regulatory landscape, and explore the nuances of current federal and provincial regulations governing this area, including new prescribing rules for nurses and pharmacists

• Analyze potential ethical dilemmas and legal challenges arising from the growth of private healthcare, such as equitable access, patient safety, and conflicts of interest

• Discuss critical implications for the pharmaceutical and MedTech industry, including proactively identifying potential risk areas and strategies to adapt compliance programs to enhance risk mitigation

• Examine key compliance considerations for developing and conducting company-sponsored training and learning activities for healthcare professionals
• Develop a robust compliance framework for managing these programs, including establishing policies and procedures, conducting thorough needs assessments, and implementing effective controls to mitigate risks

Join an interactive session delving into the essential elements of developing effective and compliant OLA programs. Attendees will:

• Develop a comprehensive understanding of the legal and regulatory framework governing OLAs, including key regulations, enforcement trends, and guidance documents
• Gain advanced insights and hone practical skills in OLA governance, emphasizing adherence to the latest regulations and industry best practices through industry case studies
• Enhance your ability to identify and mitigate compliance risks associated with OLA programs by working through scenarios

• Understand the evolving Canadian Modern Slavery Act and its specific implications for the Pharma and MedTech industries
• Develop robust due diligence strategies for third-party suppliers to minimize ethical and reputational risks
• Learn how to integrate Responsible Business Conduct principles into procurement processes to ensure compliance and ethical sourcing

• Discuss how AI can and is being used to improve efficiency, enhance governance, and proactively mitigate risks
• Review the ethical, data privacy, and other key considerations associated with emerging AI technologies and the implementation of AI in compliance functions, and explore strategies for addressing challenges
• Discuss relevant regulatory frameworks and good governance considerations for the use of AI, the compliance officer's role in overseeing these standards, and how to encourage organizational compliance with internal policies around AI